Biotech | May 25, 2022
ENPICOM launches versatile display data analysis solution to accelerate antibody selection
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
Abevmy follows the launch of the company’s two oncology biosimilars in Canada, Ogivri (bTrastuzumab) in 2019 – the first Trastuzumab approved in the country – and Fulphila (bPegfilgrastim), which was launched in 2020
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
This new fund is amongst the largest for the sector in India
Subscribe To Our Newsletter & Stay Updated
